Close Menu

NEW YORK ─ XPhyto Therapeutics and 3a-diagnostics said on Thursday that they have obtained the CE mark for a point-of-care SARS-CoV-2 RT-PCR test system, called Covid-ID Lab.

Covid-ID Lab, a multiplex viral RNA kit, requires a 20-minute PCR thermal cycle without prior RNA extraction for sample preparation and can be performed by many PCR instruments, XPhyto said. The elimination of RNA extraction for sample preparation reduces the risk of cross contamination and minimizes the need for lab materials and trained personnel, the firm added.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into.

According to the Associated Press, a Swiss program aims to shepherd long-term science projects and diplomacy.

CNN reports that two new studies suggest the B.1.1.7 SARS-CoV-2 variant may be more transmissible, but may not lead to more severe disease.

In PNAS this week: analysis of pathway affecting acute kidney injury, parental-specific allelic expression in horse placenta, and more.